Form 4: VICOR Director Sells Stock After Option Exercise
Insider Transaction Report
VICOR CORP Director Andrew D'Amico exercised stock options and subsequently sold shares totaling $57,000 under a pre-arranged 10b5-1 trading plan.
Summary
- Andrew D'Amico, a Director at VICOR CORP, engaged in transactions involving the company's common stock on January 5, 2026.
- D'Amico exercised non-qualified stock options to acquire a total of 400 shares of common stock at an exercise price of $100 per share.
- Concurrently, D'Amico sold a total of 400 shares of common stock in two separate transactions.
- The first sale involved 200 shares at $140 per share, and the second sale involved 200 shares at $145 per share.
- These sales were executed pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
- Following these transactions, D'Amico's direct beneficial ownership of common stock is 0 shares, and he retains 600 derivative securities (non-qualified stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine insider transaction involving the exercise of options and subsequent sale of shares under a pre-arranged 10b5-1 plan. It does not inherently signal strong positive or negative company performance or outlook.
Positives
- The exercise of stock options indicates that the options held value, allowing the director to acquire shares at a lower price than the market sale price.
- The sales were executed at prices ($140 and $145) higher than the exercise price ($100), indicating a profit for the director on the exercised shares.
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which demonstrates a commitment to avoiding accusations of trading on material non-public information.
Negatives
- Insider selling, even when pre-planned, can sometimes be interpreted by the market as a lack of confidence in the company's future prospects, although this is often a routine liquidity event for executives.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This is a routine insider transaction report (Form 4) and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual director's personal stock transactions.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The reporting person adopted a Rule 10b5-1 trading plan on September 12, 2024, under which the reported sales were effected. | September 12, 2024 | Enhances transparency and provides an affirmative defense against insider trading allegations by pre-scheduling trades, aligning with best practices in corporate governance for insider transactions. |
Stakeholder Impact
- Shareholders: The transactions represent a routine insider sale, which typically has minimal direct impact on the company's operations or strategic direction. While insider selling can sometimes be viewed negatively, the pre-planned nature mitigates concerns about opportunistic trading.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 06/25/2025 | Date the non-qualified stock options became exercisable. |
| 01/05/2026 | Date of all reported stock option exercises and common stock sales. |
| 01/06/2026 | Date the Form 4 was signed by the attorney-in-fact. |
| 06/25/2031 | Expiration date of the non-qualified stock options. |
Recommendation
holdThe filing details a routine insider transaction where a director exercised stock options and sold the acquired shares under a pre-arranged 10b5-1 plan. Such transactions are common for liquidity and diversification purposes and do not typically provide a strong signal for the company's future performance. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.
Keywords
VICOR CORP, VICR, Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Andrew D'Amico, 10b5-1 Plan, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.